| NSCLC | Non-small-cell lung cancer |
| miR-200 | microRNA-200 family |
| ZEB1/2 | Zinc finger E-box-binding homeobox 1/2 |
| EMT | Epithelial–mesenchymal transition |
| EGFR | Epidermal growth factor receptor |
| PD-L1 | Programmed death-ligand 1 |
| CD8+ T cell | Cluster of differentiation 8-positive T lymphocyte |
| TKI | Tyrosine kinase inhibitor |
| TGF-β | Transforming growth factor beta |
| Wnt | Wingless/INT signaling pathway |
| LEF | Lymphoid enhancer-binding factor |
| HEY1/2 | Hairy/enhancer-of-split related with YRPW motif 1/2 |
| CpG | Cytosine-phosphate-guanine dinucleotide |
| VEGFR1 | Vascular endothelial growth factor receptor 1 |
| FLT1 | Fms-related tyrosine kinase 1 |
| CXCL | C-X-C motif chemokine ligand |
| CSC | Cancer stem cell |
| CD133 | Cluster of differentiation 133 |
| ALDH1 | Aldehyde dehydrogenase 1 |
| PI3K | Phosphoinositide 3-kinase |
| AKT | Protein kinase B |
| LIN28B | Lin-28 homolog B |
| 3′-UTR | 3′ untranslated region |
| TPS | Tumor proportion score |
| PD-1 | Programmed cell death protein 1 |
| TIM-3 | T cell immunoglobulin and mucin domain-containing protein 3 |
| LAG-3 | Lymphocyte activation gene 3 |
| AUC | Area under the curve |
| RT-PCR | Reverse-transcription polymerase chain reaction |
| EV | Extracellular vesicle |
| DNMT | DNA methyltransferase |
| HDAC | Histone deacetylase |